MyFinsight
Home
Blog
About
Back
Cash Flow
Annovis Bio, Inc. (ANVS)
Annovis Bio, Inc. (ANVS)
source: myfinsight.com
Proceeds from issuance of
common stock, and...
$26,407,199
Proceeds from exercise of
common stock options
$16,285
Net cash provided by
financing activities
$26,423,484
(33.56%↑ Y/Y)
Net (decrease)
increase in cash and cash...
$4,509,864
(-31.44%↓ Y/Y)
Canceled cashflow
$21,913,620
Stock-based compensation
expense
$1,608,655
(61.43%↑ Y/Y)
Net cash used in
operating activities
-$21,913,620
(-65.95%↓ Y/Y)
Canceled cashflow
$1,608,655
Net loss
-$14,820,816
(-26.06%↓ Y/Y)
Accrued expenses
-$4,483,405
(-1852.70%↓ Y/Y)
Accounts payable
-$1,948,530
(-46.32%↓ Y/Y)
Prepaid expenses and
other current assets
$1,283,524
(35.03%↑ Y/Y)
Change in fair value of
warrants
-$986,000
(-135.89%↓ Y/Y)
Back